§

Ex Parte Schiffman

14057489 (P.T.A.B. May. 7, 2018)
Ex Parte Schiffman

22 Cited authorities

  1. Medichem, S.A. v. Rolabo, S.L

    437 F.3d 1157 (Fed. Cir. 2006)   Cited 172 times   9 Legal Analyses
    Holding that non-inventor's notebook did not corroborate reduction to practice because the non-inventor "did not testify regarding the notebook or the genuineness of its contents" and the district court was therefore "clearly reliant on the inventor to help identify the author of specific entries made in [the non-inventor's] notebook"

  2. In re Kubin

    561 F.3d 1351 (Fed. Cir. 2009)   Cited 130 times   10 Legal Analyses
    Finding patent invalid where an inherent benefit "is not an additional requirement imposed by the claims . . . but rather a property necessarily present" when the other limitations are satisfied

  3. Winner Intern. Royalty Corp. v. Wang

    202 F.3d 1340 (Fed. Cir. 2000)   Cited 152 times
    Holding that "the admission of live testimony on all matters before the Board in a section 146 action, as in this case, makes a factfinder of the district court and requires a de novo trial"

  4. In re Huai-Hung Kao

    639 F.3d 1057 (Fed. Cir. 2011)   Cited 87 times   16 Legal Analyses
    Holding that a "food effect" was obvious because the effect was an inherent property of the composition

  5. In re Mouttet

    686 F.3d 1322 (Fed. Cir. 2012)   Cited 84 times   3 Legal Analyses
    Finding "the Board's determination that eliminating the optical components of Falk would not destroy its principle of operation to be supported by substantial evidence"

  6. In re O'Farrell

    853 F.2d 894 (Fed. Cir. 1988)   Cited 163 times   9 Legal Analyses
    Finding patent obvious where the prior art provided a "reasonable expectation of success"

  7. In re Am. Academy of Science Tech Ctr.

    367 F.3d 1359 (Fed. Cir. 2004)   Cited 87 times   1 Legal Analyses
    Holding that descriptions of deficiencies of using mainframe computers set out in the "Background of the Invention" portion of the specification did not exclude mainframes from the definition of "'user computer'" where the "specification as a whole" did not express a clear disavowal of that subject matter

  8. Bayer Healthcare Pharms., Inc. v. Watson Pharms., Inc.

    713 F.3d 1369 (Fed. Cir. 2013)   Cited 41 times   2 Legal Analyses
    Holding journal citations referencing efficacy studies not sufficient to show industry praise

  9. Velander v. Garner

    348 F.3d 1359 (Fed. Cir. 2003)   Cited 56 times   2 Legal Analyses
    Reviewing the Board of Patent Appeals and Interferences' finding of a reasonable expectation of success under a "substantial evidence" standard

  10. Allied Erecting & Dismantling Co. v. Genesis Attachments, LLC

    825 F.3d 1373 (Fed. Cir. 2016)   Cited 18 times   1 Legal Analyses

    2015-1533 06-15-2016 Allied Erecting and Dismantling Co., Inc., Appellant v. Genesis Attachments, LLC, Appellee. Daniel H. Brean, The Webb Law Firm, Pittsburgh, PA, argued for appellant. Also represented by Richard L. Byrne, James G. Porcelli. Ryan Wayne Massey, Harness, Dickey & Pierce, PLC, Troy, MI, argued for appellee. Wallach, Circuit Judge. Daniel H. Brean, The Webb Law Firm, Pittsburgh, PA, argued for appellant. Also represented by Richard L. Byrne, James G. Porcelli. Ryan Wayne Massey, Harness

  11. Section 103 - Conditions for patentability; non-obvious subject matter

    35 U.S.C. § 103   Cited 6,063 times   459 Legal Analyses
    Holding the party seeking invalidity must prove "the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains."

  12. Section 6 - Patent Trial and Appeal Board

    35 U.S.C. § 6   Cited 182 times   63 Legal Analyses
    Giving the Director authority to designate "at least 3 members of the Patent Trial and Appeal Board" to review "[e]ach appeal, derivation proceeding, post-grant review, and inter partes review"

  13. Section 134 - Appeal to the Patent Trial and Appeal Board

    35 U.S.C. § 134   Cited 98 times   30 Legal Analyses

    (a) PATENT APPLICANT.-An applicant for a patent, any of whose claims has been twice rejected, may appeal from the decision of the primary examiner to the Patent Trial and Appeal Board, having once paid the fee for such appeal. (b) PATENT OWNER.-A patent owner in a reexamination may appeal from the final rejection of any claim by the primary examiner to the Patent Trial and Appeal Board, having once paid the fee for such appeal. 35 U.S.C. § 134 July 19, 1952, ch. 950, 66 Stat. 801; Pub. L. 98-622

  14. Section 41.37 - Appeal brief

    37 C.F.R. § 41.37   Cited 32 times   25 Legal Analyses
    Requiring identification of support in specification and, for means-plus-function limitations, corresponding structure as well

  15. Section 1.136 - Extensions of time

    37 C.F.R. § 1.136   Cited 15 times   28 Legal Analyses

    (a) (1) If an applicant is required to reply within a nonstatutory or shortened statutory time period, applicant may extend the time period for reply up to the earlier of the expiration of any maximum period set by statute or five months after the time period set for reply, if a petition for an extension of time and the fee set in § 1.17(a) are filed, unless: (i) Applicant is notified otherwise in an Office action; (ii) The reply is a reply brief submitted pursuant to § 41.41 of this title; (iii)

  16. Section 41.41 - Reply brief

    37 C.F.R. § 41.41   Cited 8 times   25 Legal Analyses

    (a)Timing. Appellant may file only a single reply brief to an examiner's answer within the later of two months from the date of either the examiner's answer, or a decision refusing to grant a petition under § 1.181 of this title to designate a new ground of rejection in an examiner's answer. (b)Content. (1) A reply brief shall not include any new or non-admitted amendment, or any new or non-admitted affidavit or other Evidence. See § 1.116 of this title for amendments, affidavits or other evidence

  17. Section 42.65 - Expert testimony; tests and data

    37 C.F.R. § 42.65   Cited 5 times   15 Legal Analyses
    Discussing "[e]xpert testimony"